AGVHD

Clinical trials for AGVHD explained in plain language.

Never miss a new study

Get alerted when new AGVHD trials appear

Sign up with your email to follow new studies for AGVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 2 Completed 1

New drug shows promise in controlling transplant complications

Disease control Completed

This study tested a new drug called EQ001 in 30 people who developed acute graft-versus-host disease (aGVHD) after a stem cell transplant. aGVHD is a serious condition where donor immune cells attack the patient's body. The goal was to see if EQ001 is safe and can help control th…

Matched conditions: AGVHD

Phase: PHASE1, PHASE2 • Sponsor: Biocon Limited • Aim: Disease control

Last updated Jun 27, 2026 13:07 UTC

AGVHD

Get alerted when new AGVHD trials appear

New drug shows promise in controlling transplant complications